Over 12 million people are diagnosed with cancer each year, and it is predicted to be the leading cause of death in the US by 2005. India has an estimated 2.5 milion cases and half a million new cases wil be added every year.

We are a world leader in the treatment of this devastating disease, with a broad range of products including Casodex , Arimidex and Zoladex. In 2002 we launched two new treatments, Faslodex and Iressa, and we are committed to delivering continued innovation in the fight against cancer. Some of our anti-cancer medicines are also used to treat non-malignant illnesses, such as gynaecological conditions.

Cancer is a devastating disease, predicted to be a leading cause of death in India . Currently, over 12 million new cases are diagnosed annually, worldwide. Advances in cancer treatment have significantly improved outcomes for some tumours, notably breast and prostate, but overall prognosis for survival remains poor. Restoring hope and dignity for women and men and giving them a dignified choice in the treatment of breast and prostate cancer instead of mindless castration is our mission. AstraZeneca continues to apply innovative research, development and commercial excellence in the field of oncology.

>AstraZeneca aims to be the world’s leading company in oncology by 2008, through continued research and development of innovative products, which will help patients to live longer and improve their quality of life.

Key Products

More information about our products is available by clicking on the product names below.

Arimidex (Anastrozole)

Casodex ™ (Bicalutamide)

Nolvadex (Tamoxifen citrate)

Zoladex (Goserelin)